Fractyl Health Inc (GUTS)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.70+1.35%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · GUTS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | — | — | 0.1 | 0.1 | — |
| Cost of Revenues | — | — | 0.1 | 0.1 | — |
| Gross Profit | — | — | 0.0 | 0.0 | — |
| Operating Expenses & Income | |||||
| Selling, General & Admin | 22.5 | 22.3 | 23.1 | 12.8 | — |
| R&D Expenses | 63.4 | 74.5 | 70.5 | 38.0 | — |
| Operating Income | (85.9) | (96.8) | (93.5) | (50.8) | — |
| Earnings from Continuing Operations | |||||
| Interest & Investment Income | 1.8 | 1.5 | 4.1 | 1.3 | — |
| Other Non-Operating Income / Expenses | (19.8) | (44.1) | 24.8 | (26.3) | — |
| Income Tax Expense | — | — | — | 0.0 | — |
| Net Income | |||||
| Net Income | (105.7) | (141.0) | (68.7) | (77.1) | — |
| Per Share | |||||
| Basic EPS | (0.67) | (1.86) | (1.62) | (45.29) | — |
| Diluted EPS | (0.67) | (1.86) | (1.62) | (45.29) | — |
| Basic Weighted Avg Shares | 158.6 | 75.8 | 43.5 | 2.1 | — |
| Diluted Weighted Avg Shares | 158.6 | 75.8 | 43.5 | 2.1 | — |
| Supplemental | |||||
| EBIT | (85.9) | (96.8) | (93.5) | (50.8) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.